The University of Chicago Header Logo

Connection

Daniel Arber to World Health Organization

Back to Details
This is a "connection" page, showing publications Daniel Arber has written about World Health Organization.
Daniel Arber
Connection Strength
2.150
World Health Organization
  1. The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know. Semin Hematol. 2019 04; 56(2):90-95.
    View in: PubMed
    Score: 0.549
  2. Acute myeloid leukemia. Hematol Oncol Clin North Am. 2009 Aug; 23(4):633-54.
    View in: PubMed
    Score: 0.293
  3. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. Blood. 2009 Feb 26; 113(9):1906-8.
    View in: PubMed
    Score: 0.282
  4. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022 09 15; 140(11):1200-1228.
    View in: PubMed
    Score: 0.182
  5. Revisiting erythroleukemia. Curr Opin Hematol. 2017 03; 24(2):146-151.
    View in: PubMed
    Score: 0.124
  6. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 05 19; 127(20):2391-405.
    View in: PubMed
    Score: 0.116
  7. Reclassifying myelodysplastic syndromes: what's where in the new WHO and why. Hematology Am Soc Hematol Educ Program. 2015; 2015:294-8.
    View in: PubMed
    Score: 0.107
  8. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria. Am J Clin Pathol. 2014 Dec; 142(6):803-8.
    View in: PubMed
    Score: 0.106
  9. Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System. Am J Hematol. 2025 Sep; 100(9):1566-1576.
    View in: PubMed
    Score: 0.055
  10. Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort. Blood Cancer J. 2025 May 07; 15(1):88.
    View in: PubMed
    Score: 0.055
  11. Evolution of WHO diagnostic criteria in "Classical Myeloproliferative Neoplasms" compared with the International Consensus Classification. Blood Cancer J. 2025 03 04; 15(1):31.
    View in: PubMed
    Score: 0.054
  12. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival. Am J Clin Pathol. 2003 May; 119(5):672-80.
    View in: PubMed
    Score: 0.047
  13. Response to "The WHO classification of haematolymphoid tumours" (Editorial). Leukemia. 2022 11; 36(11):2748-2749.
    View in: PubMed
    Score: 0.045
  14. Realistic pathologic classification of acute myeloid leukemias. Am J Clin Pathol. 2001 Apr; 115(4):552-60.
    View in: PubMed
    Score: 0.041
  15. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria. Mod Pathol. 2018 06; 31(6):873-880.
    View in: PubMed
    Score: 0.033
  16. Pediatric acute myeloid leukemia as classified using 2008 WHO criteria: a single-center experience. Am J Clin Pathol. 2013 Jun; 139(6):818-25.
    View in: PubMed
    Score: 0.024
  17. Protocol for the examination of specimens from patients with non-Hodgkin lymphoma/lymphoid neoplasms. Arch Pathol Lab Med. 2010 Jun; 134(6):e40-7.
    View in: PubMed
    Score: 0.019
  18. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30; 114(5):937-51.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.